Neuronostatin acts in brain to biphasically increase mean arterial pressure through sympatho-activation followed by vasopressin secretion: The role of melanocortin receptors

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 5, 2011, Pages

  Yosten, Gina L C ^a   Pate, Alicia T ^a   Samson, Willis K ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Blood pressure; Melanocortins; Vasopressin

Indexed keywords

ARGIPRESSIN; BETA MERCAPTO BETA,BETA CYCLOPENTAMETHYLENEPROPIONYL; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEURONOSTATIN 13; NEURONOSTATIN 19; NEUROPEPTIDE; PHENTOLAMINE; PLACEBO; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ADIPSIA; ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOSE RESPONSE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; LATERAL BRAIN VENTRICLE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; VASOPRESSIN RELEASE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONE ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MELANOCYTE-STIMULATING HORMONES; PEPTIDE FRAGMENTS; PHENTOLAMINE; RATS; RECEPTORS, MELANOCORTIN; RECEPTORS, VASOPRESSIN; SOMATOSTATIN; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VASOPRESSINS;

EID: 79955787385     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00849.2010     Document Type: Article

References (28)

1. Caquineau C, Leng G, Guan XMM, Jiang M, Van der Ploeg L, Douglas AJ. Effects of alpha-melanoctye-stiulating hormone on magnocellular oxytocin neurons and their activation at intromission in male rats. J Neuroendocrinol 18: 685-691, 2006.
2. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci 8: 571-578, 2005.
3. Dhillo WS, Small CJ, Seal LJ, Kim MS, Stanley SA, Murphy KG, Ghatei MA, Bloom SR. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology 75: 209-216, 2002.
4. Dunbar JC, Lu H. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides 21: 211-217, 2000.
5. Durr K, Norsted E, Comuc B, Suarez E, Hannibal J, Meister B. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) defines a subpopulation of hypothalamic POMC neurons. Brain Res 1186: 203-211, 2007.
6. Funahashi H, Yamada S, Kageyama H, Takenoya F, Guan JL, Shioda S. Co-existence of leptin- and orexin-receptors in feeding-regulating neurons in the hypothalamic arcuate nucleus-a triple labeling study. Peptides 24: 687-694, 2003.
7. Funckes CL, Minth CD, Deschenes R, Magazin M, Tavianini MA, Sheets M, Collier K, Weith HL, Aron DC, Roos BA, Dixon JE. Cloning and characterization of a mRNA-encoding rat preprosomatostatin. J Biol Chem 258: 8781-8787, 1983.
8. Giusti-Paiva A, Martinez MR, Bispo-Da-Silva LB, Salgado MCO, Elias LLK, Antunes-Rodregues J. Vasopressin mediates the pressor effect of hypertonic saline solution in endotoxic shock. Shock 27: 416-421, 2007.
9. Harms PG, Ojeda SR. A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol 36: 391-392, 1974.
10. Hill C, Dunbar JC. The effects of acute and chronic alpha melanocyte stimulating hormone (alphaMSH) on cardiovascular dynamics in conscious rats. Peptides 23: 1625-1630, 2002.
11. Janaky T, Laszlo FA, Sirokman F, Morgat JL. Biological half-life and organ distribution of [3H]8-arginine-vasopressin in the rat. J Endocrinol 93: 295-303, 1982.
12. Katz FH, Smith JA, Lock JP, Loeffel DE. Plasma vasopressin variation and rennin activity in normal active humans. Horm Res 10: 289-302, 1979.
13. Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol 22: 1723-1734, 2008.
14. Malayan SA, Ramsay DJ, Keil LC, Reid IA. Effects of increases in plasma vasopressin concentration on plasma renin activity, blood pressure, heart rate, and plasma corticosteroid concentration in conscious dogs. Endocrinology 107: 1899-1904, 1980.
15. Matsumura K, Tsuchihashi T, Abe I, Iida M. Central alpha-melanocyte- stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits. Brain Res 948: 145-148, 2002.
16. Meister B, Gomuc B, Suarez E, Ishii Y, Durr K, Gillberg L. Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype. Eur J Neurosci 24: 2731-2740, 2006.
17. Pump B, Garbielsen A, Christensen NJ, Bie P, Bestle M, Norsk P. Mechanisms of inhibition of vasopressin release during moderate antiorthostatic posture change in humans. Am J Physiol Regul Integr Comp Physiol 277: R229-R235, 1999.
18. Sabatier N, Caquineau C, Dayanithi G, Bull Douglas AJ P, Guan XMM, Jiang M, Van der Ploeg L, Leng G. Alpha-melanocotye-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J Neurosci 23: 10351-10358, 2003.
19. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage- induced vasopressin release. Neuroendocrinology 40: 277-279, 1985.
20. Samson WK, Zhang JV, Avsian-Kretchmer O, Cui K, Yosten GLC, Klein C, Lyu RM, Wang YX, Chen XQ, Yang J, Price CJ, Hoyda TD, Ferguson AV, Yuan X, Chang JK, Hsueh AJW. Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions. J Biol Chem 283: 31949-31959, 2008.
21. Shen LP, Pictet RL, Rutter WJ. Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sci USA 79: 4575-4579, 1982.
22. Tolson KP, Gemelli T, Gautron L, Elmquist JK, Zinn AR, Kublaoui BM. Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expressin. J Neurosci 30: 3803-3812, 2010.
23. Vale W, Brazeau P, Grant G, Nussey A, Burgus R, Rivier J, Ling N, Guillemin R. [Preliminary observations of the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. C R Acad Sci Hebd Seances Acad Sci D 275: 2913-2916, 1972.
24. Williams KW, Margatho LO, Lee CE, Choi M, Lee S, Scott MM, Elias CF, Elmquist JK. Segregation of acute leptin and insulin effects in distinct populations of arcuate proopiomelanocortin neurons. J Neurosci 30: 2472-2479, 2010.
25. Yosten GLC, Samson WK. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol 297: R330-R336, 2009.
26. Yosten GLC, Samson WK. The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin. Peptides 31: 1711-1714, 2010.
27. Yosten GLC, Samson WK. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatement with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 298: R1642-R1647, 2010.
28. Zar JH. Biostatistical Analysis, 2nd ed. Englewood Cliffs, NJ: Prentice- Hall, 1984.